NAFLD: Are You At Risk?

Non-alcoholic fatty liver disease (NAFLD) is a term encompassing various conditions characterized by excessive fat deposits in the liver. While it is associated with individuals who consume little to no alcohol, several lifestyle factors contribute to its development. Surprisingly common, NAFLD affects approximately 17-30% of adults according to estimates.

NAFLD can initially present without noticeable symptoms, making it difficult to detect. However, delayed diagnosis may result in liver inflammation and increase the risk of non-alcoholic steatohepatitis (NASH), which can progress to cirrhosis. Early detection and proactive management are crucial for addressing NAFLD effectively.

What Are The Symptoms Of Non-Alcoholic Fatty Liver Disease?

The early signs of Non-Alcoholic Fatty Liver Disease (NAFLD) may be subtle and easily mistaken for other health issues.

Common early symptoms include:

• Pain in the upper right abdomen
• Unexplained fatigue
• Muscle weakness
• Unintentional weight loss

Diagnosing NAFLD typically involves blood tests to assess liver function, as well as ultrasound or liver biopsy.

If you experience any of these symptoms or suspect NAFLD, it’s crucial to seek medical evaluation for timely diagnosis and appropriate management. Early detection can help prevent further complications and promote better liver health.

What Causes Non-Alcoholic Fatty Liver Disease?

Unlike alcoholic fatty liver disease, NAFLD can be influenced by various factors, and in some cases, a direct cause may not be determined. Several risk factors can lead to the development of NAFLD, including:

1. Excess Weight: Obesity is a common contributor to NAFLD, as research has shown.
   
2. Age: NAFLD risk increases with age, and childhood incidences have risen due to the prevalence of childhood obesity.
   
3. Diabetes: NAFLD and diabetes have a reciprocal relationship, each raising the risk of the other. Fortunately, lifestyle changes beneficial for one condition can also help manage the other.
   
4. Insulin Resistance: Up to 80% of obese and diabetic individuals may develop NAFLD due to the close connection between insulin metabolism and NAFLD risk.
   
5. Cholesterol: High cholesterol levels can lead to fatty liver deposits.
   
6. Thyroid Problems: Hypothyroidism has been linked to NAFLD in some studies.
   
7. Sleep Apnea: People with sleep apnea are more likely to have NAFLD, even when accounting for obesity, a shared risk factor.
   
8. Polycystic Ovary Disease (PCOS): Many women with PCOS also have NAFLD, with excess weight and androgen levels contributing to both conditions.

Recognizing and addressing these risk factors can play a crucial role in preventing and managing NAFLD effectively. If you suspect any of these risk factors apply to you, seeking medical evaluation and making necessary lifestyle changes can promote better liver health.

Holistic Treatment Options For NAFLD

To date, conventional medications for NAFLD treatment are limited. However, addressing the root causes not only promotes liver healing but also offers other health benefits.

Here are essential tips to help prevent NAFLD and minimize liver damage:

1. Lose Weight: Excess weight significantly increases NAFLD risk. Focus on adopting a realistic, healthy weight loss approach that you can sustain long-term.
   
2. Supplement Wisely: Initial research suggests that vitamin E can protect the liver. Other supplements like curcumin, vitamin D, omega-3, and berberine show promising results. Always consult your healthcare practitioner for the right approach for you.
   
3. Adopt a Balanced Diet: Prioritize whole foods, including whole grains, lean protein, and fresh produce. The Mediterranean diet, rich in fish, vegetables, healthy fats, nuts, and olive oil, aids NAFLD management. Reducing sugar intake is crucial to avoiding NAFLD.
   
4. Maintain a Healthy Microbiome: Gut bacteria play a vital role in liver fat metabolism. Consume high-fiber and fermented foods like sauerkraut and kefir, and consider probiotic supplements.
   
5. Stay Active: Regular exercise improves insulin resistance and liver fatty acid metabolism. A mix of steady-state cardio, weight training, and high-intensity intervals is ideal. Create a sustainable exercise program that suits your needs.

Prioritize your liver health today! If experiencing NAFLD symptoms or seeking proactive liver care, we can collaborate to implement a comprehensive plan for your well-being.

Sources:

Kneeman JM, Misdraji J, Corey KE. Secondary causes of nonalcoholic fatty liver disease. Therap Adv Gastroenterol. 2012 May;5(3):199-207. doi: 10.1177/1756283X11430859. PMID: 22570680; PMCID: PMC3342568.

Chung GE, Kim D, Kim W, Yim JY, Park MJ, Kim YJ, Yoon JH, Lee HS. Non-alcoholic fatty liver disease across the spectrum of hypothyroidism. J Hepatol. 2012 Jul;57(1):150-6. doi: 10.1016/j.jhep.2012.02.027. Epub 2012 Mar 14. PMID: 22425701.

Chung GE, Kim D, Kim W et al. Non-alcoholic fatty liver disease across the spectrum of hypothyroidism. J Hepatol [published online ahead of print March 13, 2012]. http://www.ncbi.nlm.nih.gov/pubmed/22425701

Mesarwi OA, Loomba R, Malhotra A. Obstructive Sleep Apnea, Hypoxia, and Nonalcoholic Fatty Liver Disease. Am J Respir Crit Care Med. 2019 Apr 1;199(7):830-841. doi: 10.1164/rccm.201806-1109TR. PMID: 30422676; PMCID: PMC6835083.

Hazlehurst JM, Woods C, Marjot T, Cobbold JF, Tomlinson JW. Non-alcoholic fatty liver disease and diabetes. Metabolism. 2016 Aug;65(8):1096-108. doi: 10.1016/j.metabol.2016.01.001. Epub 2016 Jan 11. PMID: 26856933; PMCID: PMC4943559.

Kitade H, Chen G, Ni Y, Ota T. Nonalcoholic Fatty Liver Disease and Insulin Resistance: New Insights and Potential New Treatments. Nutrients. 2017 Apr 14;9(4):387. doi: 10.3390/nu9040387. PMID: 28420094; PMCID: PMC5409726.

Vassilatou E. Nonalcoholic fatty liver disease and polycystic ovary syndrome. World J Gastroenterol. 2014 Jul 14;20(26):8351-63. doi: 10.3748/wjg.v20.i26.8351. PMID: 25024594; PMCID: PMC4093689.

Usman M, Bakhtawar N. Vitamin E as an Adjuvant Treatment for Non-alcoholic Fatty Liver Disease in Adults: A Systematic Review of Randomized Controlled Trials. Cureus. 2020 Jul 6;12(7):e9018. doi: 10.7759/cureus.9018. PMID: 32775098; PMCID: PMC7405968.

Zelber-Sagi S, Salomone F, Mlynarsky L. The Mediterranean dietary pattern as the diet of choice for non-alcoholic fatty liver disease: Evidence and plausible mechanisms. Liver Int. 2017 Jul;37(7):936-949. doi: 10.1111/liv.13435. Epub 2017 Jun 1. PMID: 28371239

Campo L, Eiseler S, Apfel T, Pyrsopoulos N. Fatty Liver Disease and Gut Microbiota: A Comprehensive Update. J Clin Transl Hepatol. 2019 Mar 28;7(1):56-60. doi: 10.14218/JCTH.2018.00008. Epub 2018 Dec 28. PMID: 30944821; PMCID: PMC6441642.

Jensen T, Abdelmalek MF, Sullivan S, Nadeau KJ, Green M, Roncal C, Nakagawa T, Kuwabara M, Sato Y, Kang DH, Tolan DR, Sanchez-Lozada LG, Rosen HR, Lanaspa MA, Diehl AM, Johnson RJ. Fructose and sugar: A major mediator of non-alcoholic fatty liver disease. J Hepatol. 2018 May;68(5):1063-1075. doi: 10.1016/j.jhep.2018.01.019. Epub 2018 Feb 2. PMID: 29408694; PMCID:

van der Windt DJ, Sud V, Zhang H, Tsung A, Huang H. The Effects of Physical Exercise on Fatty Liver Disease. Gene Expr. 2018 May 18;18(2):89-101. doi: 10.3727/105221617X15124844266408. Epub 2017 Dec 6. PMID: 29212576; PMCID: PMC5954622.